Rodin Therapeutics Lands $12,900,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
    Rodin Therapeutics
  • Mailing Address
    Undisclosed Cambridge, MA 02138 USA
  • Company Description
    Rodin Therapeutics is a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Rodin will use the new funds to advance its pipeline of selective epigenetic modulators towards the clinic.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy